WaveDancer

WaveDancer has entered into a definitive merger agreement with Firefly Neuroscience, Inc. to combine the companies in an all-stock transaction. The merger aims to focus on developing and commercializing Firefly’s Artificial Intelligence driven Brain Network Analytics (BNA™) platform, which has been cleared by the U.S. Food and Drug Administration. Upon the expected closing of the merger in Q1-2024, the combined company will operate under the name Firefly Neuroscience, Inc. and will trade on the Nasdaq Global Market. WaveDancer currently provides IT development, modernization efforts, and cybersecurity programs through its subsidiary Tellenger, Inc. However, Tellenger, a provider of modernization services to the federal government, will be divested through a transaction closing simultaneous to the Firefly merger.